",n.parentNode.insertBefore(a,n)};if(!!document.cookie.match(/cookieConsent=true/))window.gaf(); ',{'forceSSL':true});
therapeutic areas
oncology
retinal disease
animal health
Kalos successfully leverages the diuretic and therapeutic effects of ANP to replace Lasix (furosemide), banned as a race day medication in Thoroughbred racehorses and other competition horses. The equine market is over a billion dollars per annum globally, and revenue for our animal health division is anticipated within two calendar years.
antivirals
Kalos peptides inhibited up to 40% of COV-2 spike peptides from its binding domain in the ACE receptor, demonstrating a peptide-peptide interaction producing inhibition. This ability to treat very ill patients who are hospitalized and dosed intravenously is an advance for treating this disease in all patients.
This website makes use of cookies. Please see our privacy policy for details.